The mandate for the committee shall encompass at least a benefit-risk assessment of the presence of phthalates which belong to either of the groups of substances referred to in points (a) and (b) of Section 10.4.1.
Cuimseofar, sa sainordú don choiste, ar a laghad measúnú tairbhe-riosca ar thaláití a bheith ann a bhaineann le ceachtar de na grúpaí substaintí dá dtagraítear i bpointe (a) agus i bpointe (b) de Roinn 10.4.1.